Fingerprint
Dive into the research topics of 'Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in hiv-1-infected treatment-experienced patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in hiv-1-infected treatment-experienced patients
Timothy J. Wilkin, Zhaohui Su, Amy Krambrink, Jianmin Long, Wayne Greaves, Robert Gross, Michael D. Hughes, Charles Flexner, Paul R. Skolnik, Eoin Coakley, Catherine Godfrey, Martin Hirsch, Daniel R. Kuritzkes, Roy M. Gulick
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations